CDH1 and breast carcinoma: Our data showing drug efficacy in breast MCF10A isogenic cells and mouse mammary organoids also suggest that CDH1 synthetic lethal drugs, such as entinostat, may also be effective in reducing the risk of LBC and lobular carcinoma in situ (LCIS) in HDGC families.